BACKGROUND: Persons infected with human immunodeficiency virus (HIV) have increased rates of coronary artery disease (CAD). The relative contribution of genetic background, HIV-related factors, antiretroviral medications, and traditional risk factors to CAD has not been fully evaluated in the setting of HIV infection. METHODS: In the general population, 23 common single-nucleotide polymorphisms (SNPs) were shown to be associated with CAD through genome-wide association analysis. Using the Metabochip, we genotyped 1875 HIV-positive, white individuals enrolled in 24 HIV observational studies, including 571 participants with a first CAD event during the 9-year study period and 1304 controls matched on sex and cohort. RESULTS: A genetic risk score built from 23 CAD-associated SNPs contributed significantly to CAD (P = 2.9 × 10(-4)). In the final multivariable model, participants with an unfavorable genetic background (top genetic score quartile) had a CAD odds ratio (OR) of 1.47 (95% confidence interval [CI], 1.05-2.04). This effect was similar to hypertension (OR = 1.36; 95% CI, 1.06-1.73), hypercholesterolemia (OR = 1.51; 95% CI, 1.16-1.96), diabetes (OR = 1.66; 95% CI, 1.10-2.49), ≥ 1 year lopinavir exposure (OR = 1.36; 95% CI, 1.06-1.73), and current abacavir treatment (OR = 1.56; 95% CI, 1.17-2.07). The effect of the genetic risk score was additive to the effect of nongenetic CAD risk factors, and did not change after adjustment for family history of CAD. CONCLUSIONS: In the setting of HIV infection, the effect of an unfavorable genetic background was similar to traditional CAD risk factors and certain adverse antiretroviral exposures. Genetic testing may provide prognostic information complementary to family history of CAD.

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons / M., Rotger; T. R., Glass; T., Junier; J., Lundgren; J. D., Neaton; E. S., Poloni; A. B., van 't Wout; R., Lubomirov; S., Colombo; R., Martinez; A., Rauch; H. F., Gunthard; J., Neuhaus; D., Wentworth; D., van Manen; L. A., Gras; H., Schuitemaker; L., Albini; C., Torti; L. P., Jacobson; X., Li; L. A., Kingsley; Carli, Federica; Guaraldi, Giovanni; E. S., Ford; I., Sereti; C., Hadigan; E., Martinez; M., Arnedo; L., Egana Gorrono; J. M., Gatell; M., Law; C., Bendall; K., Petoumenos; J., Rockstroh; J. C., Wasmuth; K., Kabamba; M., Delforge; S., De Wit; F., Berger; S., Mauss; M., de Paz Sierra; M., Losso; W. H., Belloso; M., Leyes; A., Campins; A., Mondi; A., De Luca; I., Bernardino; M., Barriuso Iglesias; A., Torrecilla Rodriguez; J., Gonzalez Garcia; J. R., Arribas; I., Fanti; S., Gel; J., Puig; E., Negredo; M., Gutierrez; P., Domingo; J., Fischer; G., Fatkenheuer; C., Alonso Villaverde; A., Macken; J., Woo; T., Mcginty; P., Mallon; A., Mangili; S., Skinner; C. A., Wanke; P., Reiss; R., Weber; H. C., Bucher; J., Fellay; A., Telenti; P. E., Tarr. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - STAMPA. - 57:1(2013), pp. 112-121. [10.1093/cid/cit196]

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

CARLI, FEDERICA;GUARALDI, Giovanni;
2013

Abstract

BACKGROUND: Persons infected with human immunodeficiency virus (HIV) have increased rates of coronary artery disease (CAD). The relative contribution of genetic background, HIV-related factors, antiretroviral medications, and traditional risk factors to CAD has not been fully evaluated in the setting of HIV infection. METHODS: In the general population, 23 common single-nucleotide polymorphisms (SNPs) were shown to be associated with CAD through genome-wide association analysis. Using the Metabochip, we genotyped 1875 HIV-positive, white individuals enrolled in 24 HIV observational studies, including 571 participants with a first CAD event during the 9-year study period and 1304 controls matched on sex and cohort. RESULTS: A genetic risk score built from 23 CAD-associated SNPs contributed significantly to CAD (P = 2.9 × 10(-4)). In the final multivariable model, participants with an unfavorable genetic background (top genetic score quartile) had a CAD odds ratio (OR) of 1.47 (95% confidence interval [CI], 1.05-2.04). This effect was similar to hypertension (OR = 1.36; 95% CI, 1.06-1.73), hypercholesterolemia (OR = 1.51; 95% CI, 1.16-1.96), diabetes (OR = 1.66; 95% CI, 1.10-2.49), ≥ 1 year lopinavir exposure (OR = 1.36; 95% CI, 1.06-1.73), and current abacavir treatment (OR = 1.56; 95% CI, 1.17-2.07). The effect of the genetic risk score was additive to the effect of nongenetic CAD risk factors, and did not change after adjustment for family history of CAD. CONCLUSIONS: In the setting of HIV infection, the effect of an unfavorable genetic background was similar to traditional CAD risk factors and certain adverse antiretroviral exposures. Genetic testing may provide prognostic information complementary to family history of CAD.
2013
57
1
112
121
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons / M., Rotger; T. R., Glass; T., Junier; J., Lundgren; J. D., Neaton; E. S., Poloni; A. B., van 't Wout; R., Lubomirov; S., Colombo; R., Martinez; A., Rauch; H. F., Gunthard; J., Neuhaus; D., Wentworth; D., van Manen; L. A., Gras; H., Schuitemaker; L., Albini; C., Torti; L. P., Jacobson; X., Li; L. A., Kingsley; Carli, Federica; Guaraldi, Giovanni; E. S., Ford; I., Sereti; C., Hadigan; E., Martinez; M., Arnedo; L., Egana Gorrono; J. M., Gatell; M., Law; C., Bendall; K., Petoumenos; J., Rockstroh; J. C., Wasmuth; K., Kabamba; M., Delforge; S., De Wit; F., Berger; S., Mauss; M., de Paz Sierra; M., Losso; W. H., Belloso; M., Leyes; A., Campins; A., Mondi; A., De Luca; I., Bernardino; M., Barriuso Iglesias; A., Torrecilla Rodriguez; J., Gonzalez Garcia; J. R., Arribas; I., Fanti; S., Gel; J., Puig; E., Negredo; M., Gutierrez; P., Domingo; J., Fischer; G., Fatkenheuer; C., Alonso Villaverde; A., Macken; J., Woo; T., Mcginty; P., Mallon; A., Mangili; S., Skinner; C. A., Wanke; P., Reiss; R., Weber; H. C., Bucher; J., Fellay; A., Telenti; P. E., Tarr. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - STAMPA. - 57:1(2013), pp. 112-121. [10.1093/cid/cit196]
M., Rotger; T. R., Glass; T., Junier; J., Lundgren; J. D., Neaton; E. S., Poloni; A. B., van 't Wout; R., Lubomirov; S., Colombo; R., Martinez; A., Rauch; H. F., Gunthard; J., Neuhaus; D., Wentworth; D., van Manen; L. A., Gras; H., Schuitemaker; L., Albini; C., Torti; L. P., Jacobson; X., Li; L. A., Kingsley; Carli, Federica; Guaraldi, Giovanni; E. S., Ford; I., Sereti; C., Hadigan; E., Martinez; M., Arnedo; L., Egana Gorrono; J. M., Gatell; M., Law; C., Bendall; K., Petoumenos; J., Rockstroh; J. C., Wasmuth; K., Kabamba; M., Delforge; S., De Wit; F., Berger; S., Mauss; M., de Paz Sierra; M., Losso; W. H., Belloso; M., Leyes; A., Campins; A., Mondi; A., De Luca; I., Bernardino; M., Barriuso Iglesias; A., Torrecilla Rodriguez; J., Gonzalez Garcia; J. R., Arribas; I., Fanti; S., Gel; J., Puig; E., Negredo; M., Gutierrez; P., Domingo; J., Fischer; G., Fatkenheuer; C., Alonso Villaverde; A., Macken; J., Woo; T., Mcginty; P., Mallon; A., Mangili; S., Skinner; C. A., Wanke; P., Reiss; R., Weber; H. C., Bucher; J., Fellay; A., Telenti; P. E., Tarr
File in questo prodotto:
File Dimensione Formato  
contribution of genetic_2013.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 474.31 kB
Formato Adobe PDF
474.31 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/969509
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 51
social impact